Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson's disease.

Eidson LN, Kannarkat GT, Barnum CJ, Chang J, Chung J, Caspell-Garcia C, Taylor P, Mollenhauer B, Schlossmacher MG, Ereshefsky L, Yen M, Kopil C, Frasier M, Marek K, Hertzberg VS, Tansey MG.

J Neuroinflammation. 2017 Aug 18;14(1):164. doi: 10.1186/s12974-017-0935-1.

2.

Chronic psychological stress and high-fat high-fructose diet disrupt metabolic and inflammatory gene networks in the brain, liver, and gut and promote behavioral deficits in mice.

de Sousa Rodrigues ME, Bekhbat M, Houser MC, Chang J, Walker DI, Jones DP, Oller do Nascimento CMP, Barnum CJ, Tansey MG.

Brain Behav Immun. 2017 Jan;59:158-172. doi: 10.1016/j.bbi.2016.08.021. Epub 2016 Sep 2.

3.

Effects of the beta-adrenergic receptor antagonist Propranolol on dyskinesia and L-DOPA-induced striatal DA efflux in the hemi-parkinsonian rat.

Bhide N, Lindenbach D, Barnum CJ, George JA, Surrena MA, Bishop C.

J Neurochem. 2015 Jul;134(2):222-32. doi: 10.1111/jnc.13125. Epub 2015 Apr 27.

4.

Two weeks of predatory stress induces anxiety-like behavior with co-morbid depressive-like behavior in adult male mice.

Burgado J, Harrell CS, Eacret D, Reddy R, Barnum CJ, Tansey MG, Miller AH, Wang H, Neigh GN.

Behav Brain Res. 2014 Dec 15;275:120-5. doi: 10.1016/j.bbr.2014.08.060. Epub 2014 Sep 6.

5.

Simultaneous imaging of locus coeruleus and substantia nigra with a quantitative neuromelanin MRI approach.

Chen X, Huddleston DE, Langley J, Ahn S, Barnum CJ, Factor SA, Levey AI, Hu X.

Magn Reson Imaging. 2014 Dec;32(10):1301-6. doi: 10.1016/j.mri.2014.07.003. Epub 2014 Jul 31.

PMID:
25086330
6.

Peripheral administration of the selective inhibitor of soluble tumor necrosis factor (TNF) XPro®1595 attenuates nigral cell loss and glial activation in 6-OHDA hemiparkinsonian rats.

Barnum CJ, Chen X, Chung J, Chang J, Williams M, Grigoryan N, Tesi RJ, Tansey MG.

J Parkinsons Dis. 2014;4(3):349-60. doi: 10.3233/JPD-140410.

7.

The impact of ventral noradrenergic bundle lesions on increased IL-1 in the PVN and hormonal responses to stress in male sprague dawley rats.

Blandino P Jr, Hueston CM, Barnum CJ, Bishop C, Deak T.

Endocrinology. 2013 Jul;154(7):2489-500. doi: 10.1210/en.2013-1075. Epub 2013 May 13.

PMID:
23671261
8.

Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity.

Sanchez-Guajardo V, Barnum CJ, Tansey MG, Romero-Ramos M.

ASN Neuro. 2013 Apr 30;5(2):113-39. doi: 10.1042/AN20120066. Review.

9.

Neuroinflammation and non-motor symptoms: the dark passenger of Parkinson's disease?

Barnum CJ, Tansey MG.

Curr Neurol Neurosci Rep. 2012 Aug;12(4):350-8. doi: 10.1007/s11910-012-0283-6. Review.

PMID:
22580742
10.

Psychological stress in adolescent and adult mice increases neuroinflammation and attenuates the response to LPS challenge.

Barnum CJ, Pace TW, Hu F, Neigh GN, Tansey MG.

J Neuroinflammation. 2012 Jan 16;9:9. doi: 10.1186/1742-2094-9-9.

11.

Effects of noradrenergic denervation on L-DOPA-induced dyskinesia and its treatment by α- and β-adrenergic receptor antagonists in hemiparkinsonian rats.

Barnum CJ, Bhide N, Lindenbach D, Surrena MA, Goldenberg AA, Tignor S, Klioueva A, Walters H, Bishop C.

Pharmacol Biochem Behav. 2012 Jan;100(3):607-15. doi: 10.1016/j.pbb.2011.09.009. Epub 2011 Sep 25.

12.

Stress-dependent changes in neuroinflammatory markers observed after common laboratory stressors are not seen following acute social defeat of the Sprague Dawley rat.

Hueston CM, Barnum CJ, Eberle JA, Ferraioli FJ, Buck HM, Deak T.

Physiol Behav. 2011 Aug 3;104(2):187-98. doi: 10.1016/j.physbeh.2011.03.013. Epub 2011 Mar 23.

PMID:
21406198
13.

Behavioral and cellular modulation of L-DOPA-induced dyskinesia by beta-adrenoceptor blockade in the 6-hydroxydopamine-lesioned rat.

Lindenbach D, Ostock CY, Eskow Jaunarajs KL, Dupre KB, Barnum CJ, Bhide N, Bishop C.

J Pharmacol Exp Ther. 2011 Jun;337(3):755-65. doi: 10.1124/jpet.111.179416. Epub 2011 Mar 14.

14.

The duality of TNF signaling outcomes in the brain: potential mechanisms?

Barnum CJ, Tansey MG.

Exp Neurol. 2011 Jun;229(2):198-200. doi: 10.1016/j.expneurol.2011.02.016. Epub 2011 Mar 4. No abstract available.

PMID:
21377463
15.

Delayed dominant-negative TNF gene therapy halts progressive loss of nigral dopaminergic neurons in a rat model of Parkinson's disease.

Harms AS, Barnum CJ, Ruhn KA, Varghese S, Treviño I, Blesch A, Tansey MG.

Mol Ther. 2011 Jan;19(1):46-52. doi: 10.1038/mt.2010.217. Epub 2010 Oct 19.

16.

Modeling neuroinflammatory pathogenesis of Parkinson's disease.

Barnum CJ, Tansey MG.

Prog Brain Res. 2010;184:113-32. doi: 10.1016/S0079-6123(10)84006-3. Review.

PMID:
20887872
17.

Gene expression changes in the hypothalamus provide evidence for regionally-selective changes in IL-1 and microglial markers after acute stress.

Blandino P Jr, Barnum CJ, Solomon LG, Larish Y, Lankow BS, Deak T.

Brain Behav Immun. 2009 Oct;23(7):958-68. doi: 10.1016/j.bbi.2009.04.013. Epub 2009 May 21.

PMID:
19464360
18.

The role of the dorsal raphe nucleus in the development, expression, and treatment of L-dopa-induced dyskinesia in hemiparkinsonian rats.

Eskow KL, Dupre KB, Barnum CJ, Dickinson SO, Park JY, Bishop C.

Synapse. 2009 Jul;63(7):610-20. doi: 10.1002/syn.20630.

19.

Contribution of the striatum to the effects of 5-HT1A receptor stimulation in L-DOPA-treated hemiparkinsonian rats.

Bishop C, Krolewski DM, Eskow KL, Barnum CJ, Dupre KB, Deak T, Walker PD.

J Neurosci Res. 2009 May 15;87(7):1645-58. doi: 10.1002/jnr.21978.

20.

Striatal 5-HT1A receptor stimulation reduces D1 receptor-induced dyskinesia and improves movement in the hemiparkinsonian rat.

Dupre KB, Eskow KL, Barnum CJ, Bishop C.

Neuropharmacology. 2008 Dec;55(8):1321-8. doi: 10.1016/j.neuropharm.2008.08.031. Epub 2008 Sep 10.

21.

Exogenous corticosterone reduces L-DOPA-induced dyskinesia in the hemi-parkinsonian rat: role for interleukin-1beta.

Barnum CJ, Eskow KL, Dupre K, Blandino P Jr, Deak T, Bishop C.

Neuroscience. 2008 Sep 22;156(1):30-41. doi: 10.1016/j.neuroscience.2008.07.016. Epub 2008 Jul 12.

22.

Social status modulates basal IL-1 concentrations in the hypothalamus of pair-housed rats and influences certain features of stress reactivity.

Barnum CJ, Blandino P Jr, Deak T.

Brain Behav Immun. 2008 May;22(4):517-27. Epub 2007 Nov 26.

PMID:
18037266
23.

Adaptation in the corticosterone and hyperthermic responses to stress following repeated stressor exposure.

Barnum CJ, Blandino P Jr, Deak T.

J Neuroendocrinol. 2007 Aug;19(8):632-42.

PMID:
17620105
24.

The involvement of norepinephrine and microglia in hypothalamic and splenic IL-1beta responses to stress.

Blandino P Jr, Barnum CJ, Deak T.

J Neuroimmunol. 2006 Apr;173(1-2):87-95. Epub 2006 Jan 4.

PMID:
16386803
25.

Stress-induced increases in hypothalamic IL-1: a systematic analysis of multiple stressor paradigms.

Deak T, Bordner KA, McElderry NK, Barnum CJ, Blandino P Jr, Deak MM, Tammariello SP.

Brain Res Bull. 2005 Jan 30;64(6):541-56.

PMID:
15639551

Supplemental Content

Loading ...
Support Center